According to FDA statement, Becton Dickinson (BDX) is “recalling one lot of ChloraPrep Clear 1 mL applicators due to fungal contamination under ...

Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...

The global butterfly needle sets market is witnessing significant expansion, driven by increasing chronic disease prevalence, advancements in medical technology, and growing demand for minimally ...

According to the company, medical essentials and interventional lead the medical technology unit's business lines, bringing ...

Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Syringes and Needles MarketThe sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to ...